Lung Cancer

Inoperable lung cancer treated by radiofrequency ablation plus conventional radiotherapy

Published in Cancer Weekly, May 29th, 2006

Stage I non-small cell lung cancer (NSCLC) could be treated by radiofrequency ablation (RFA) followed by conventional radiotherapy.

According to recent research from the United States, "The standard treatment of stage I NSCLC is surgical resection. Some patients are poor surgical candidates due to severe comorbid medical conditions."

"Radiotherapy alone has historically been used in this patient population with limited success," explained D.E. Dupuy and colleagues, Rhode Island Hospital. "RFA is an image-guided, thermally mediated ablative technique recently applied to lung tumors. Combination therapy with both these treatments has not been...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2006-05-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry